• No results found

PD—Parkinson's disease

Atypical antipsychotics for Parkinson’s disease psychosis: a systematic review and meta-analysis

<p>Atypical antipsychotics for Parkinson&rsquo;s disease psychosis: a systematic review and meta-analysis</p>

... PDPsy, Parkinsons disease psy- chosis; RCTs, Randomized controlled trials; PD, Parkinsons disease; WMD, Weighted mean difference; CI, Con fi dence interval; SD, ...

13

Altered regional homogeneity of prefrontal cortex in Parkinson’s disease with mild cognitive impairment

Altered regional homogeneity of prefrontal cortex in Parkinson’s disease with mild cognitive impairment

... PD: Parkinsons disease; HC: Healthy control; PDNC: PD with normal cognition; PD-MCI: PD with mild cognitive impairment; ReHo: Regional homogeneity; rs-fMRI: Resting ...

7

Study protocol of “CHAPS”: a randomized controlled trial protocol of Care Coordination for Health Promotion and Activities in Parkinson’s Disease to improve the quality of care for individuals with Parkinson’s disease

Study protocol of “CHAPS”: a randomized controlled trial protocol of Care Coordination for Health Promotion and Activities in Parkinson’s Disease to improve the quality of care for individuals with Parkinson’s disease

... PD: Parkinsons disease; CHAPS: Care coordination for health promotion and activities in Parkinsons disease; VA: Veterans health administration; CCM: Chronic care ...

13

Pros and cons of a prion-like pathogenesis in Parkinson's disease

Pros and cons of a prion-like pathogenesis in Parkinson's disease

... of PD, whereas LB are not present in ...in PD patients so far. Finally, disease modi- fying substances have been found in PD animal models in vitro, while no such agents are currently ...

5

Incidence of Free of Charge Physiotherapy in a Danish National Cohort of Stroke, Parkinson&rsquo;s Disease, Multiple Sclerosis and Rheumatoid Arthritis Patients

<p>Incidence of Free of Charge Physiotherapy in a Danish National Cohort of Stroke, Parkinson&rsquo;s Disease, Multiple Sclerosis and Rheumatoid Arthritis Patients</p>

... with PD and MS, the proportion of patients receiving FCP increased over the period of ...in PD and MS ...with PD in 2007 indicates the immediate effect of the legislative changes in this patient ...

7

Ambroxol as a novel disease-modifying treatment for Parkinson’s disease dementia: protocol for a single-centre, randomized, double-blind, placebo-controlled trial

Ambroxol as a novel disease-modifying treatment for Parkinson’s disease dementia: protocol for a single-centre, randomized, double-blind, placebo-controlled trial

... Parkinson’s disease, and conse- quently ...of PD that Ambroxol can raise levels of ...of disease-modifying therapies for PDD and other synuclei- nopathies including Parkinson’s disease and ...

10

Health-related quality of life and strain in caregivers of Australians with Parkinson’s disease: An observational study

Health-related quality of life and strain in caregivers of Australians with Parkinson’s disease: An observational study

... with PD and their caregivers in their UK sample of > 700 dyads using the SF12 ...long-standing disease; 35% of patients had been diagnosed for five to ten years and 32% for longer than 10 years, whereas ...

7

Italian validation of the Belastungsfragebogen Parkinson kurzversion (BELA-P-k): a disease-specific questionnaire for evaluation of the subjective perception of quality of life in parkinson’s disease

Italian validation of the Belastungsfragebogen Parkinson kurzversion (BELA-P-k): a disease-specific questionnaire for evaluation of the subjective perception of quality of life in parkinson’s disease

... ’ s QoL is a crucial goal for clinicians involved in rehabilitative ...with Parkinsons Disease (PD), in this study we have first translated and then validated the ...

6

Development of an ultra-high sensitive immunoassay with plasma biomarker for differentiating Parkinson disease dementia from Parkinson disease using antibody functionalized magnetic nanoparticles

Development of an ultra-high sensitive immunoassay with plasma biomarker for differentiating Parkinson disease dementia from Parkinson disease using antibody functionalized magnetic nanoparticles

... early-stage PD samples without dementia than controls ...in PD without dementia, which implies the α-synuclein burden in plasma is more severe in PDD than in ...in PD with normal cognition, which ...

8

Patient and physician perceptions of disease management in Parkinson&rsquo;s disease: results from a US-based multicenter survey

<p>Patient and physician perceptions of disease management in Parkinson&rsquo;s disease: results from a US-based multicenter survey</p>

... with PD in this ...earlier-stage PD, 5 despite the relatively low impact of tremor on patients ’ overall health status 18,19 and the incon- sistent response of tremor to current medical ...change PD ...

9

Parkinson&rsquo;s disease-associated dysarthria: prevalence, impact and management strategies

<p>Parkinson&rsquo;s disease-associated dysarthria: prevalence, impact and management strategies</p>

... in PD is strongly supported by scienti fi c evi- dence across all stages of the ...idiopathic PD and observed an increase in sound pressure level (SPL, the acoustic correlate of vocal loudness) in the ON ...

8

Effects of yoga on oxidative stress, motor function, and non-motor symptoms in Parkinson’s disease: a pilot randomized controlled trial

Effects of yoga on oxidative stress, motor function, and non-motor symptoms in Parkinson’s disease: a pilot randomized controlled trial

... the PD popula- ...for PD established with an expert panel of yoga teachers, use of a RCT design, and the inclusion of the longer post-intervention follow-up ...

11

Clinical characteristics of impulse control and related disorders in Chinese Parkinson’s disease patients

Clinical characteristics of impulse control and related disorders in Chinese Parkinson’s disease patients

... in PD patients with ICRDs (measured by MMSE) in our ...in PD subjects is still debatable according to previous studies [12, 15, ...with PD patients have gait disturbance were more prone to developed ...

6

Particulate matter and risk of parkinson disease in a large prospective study of women

Particulate matter and risk of parkinson disease in a large prospective study of women

... ascertain PD cases has been de- scribed previously ...of PD in the NHS have been identified through biennial ...reports PD, con- sent is sought from the participant to contact their treat- ing ...

9

Neuroinflammation and fractalkine signaling in Alzheimer’s disease

Neuroinflammation and fractalkine signaling in Alzheimer’s disease

... CX3CR1 knock out in several models of neurodegenera- tion. Broadly, they found that microglia lacking CX3CR1 are cytotoxic in models of systemic inflammation, amyo- trophic lateral sclerosis (ALS), and Parkinson’s ...

8

Retinal nerve fibre layer loss in hereditary spastic paraplegias is restricted to complex phenotypes

Retinal nerve fibre layer loss in hereditary spastic paraplegias is restricted to complex phenotypes

... single disease entities as previously suggested ...different disease entities even though there are still controversial findings to report on: ...Parkinson’s disease (PD), one study showed the ...

6

Urological dysfunctions in patients with Parkinson’s disease: clues from clinical and non-invasive urological assessment

Urological dysfunctions in patients with Parkinson’s disease: clues from clinical and non-invasive urological assessment

... Non-demented PD patients were consecutively enrolled from the outpatients clinic of our ...in Parkinsons disease (SCOPA-AUT) ...187 PD patients met the inclusion criteria and were ...

5

The Parkin’Play study: protocol of a phase II randomized controlled trial to assess the effects of a health game on cognition in Parkinson’s disease

The Parkin’Play study: protocol of a phase II randomized controlled trial to assess the effects of a health game on cognition in Parkinson’s disease

... Parkinson’s disease (PD) are now recognized as major contributors to a decreased quality of life [1, ...of PD patients, even in early stages of the disease, and cognitive deficits typically ...

11

Activities of daily living questionnaire from patients’ perspectives in Parkinson’s disease: a cross-sectional study

Activities of daily living questionnaire from patients’ perspectives in Parkinson’s disease: a cross-sectional study

... Parkinson’s Disease Rating Scale (UPDRS) is widely used to assess mentation, ADL, motor symptoms, and treatment complications in patients with PD ...

7

Small (autonomic) and large fiber neuropathy in Parkinson disease and parkinsonism

Small (autonomic) and large fiber neuropathy in Parkinson disease and parkinsonism

... neurological exam looking for classicial findings of neuro- pathy (predominantly distal atrophy, decreased or ab- sent deep tendon reflexes, length-dependent sensory loss). Thereafter, a group of medical students super- ...

7

Show all 10000 documents...

Related subjects